文献速递血管炎

带状疱疹与巨细胞动脉炎发病风险相关

Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.
PubMed 文献 · Arthritis Rheumatol · 2017-11-09

基于美国两个大型行政数据库的回顾性队列研究,纳入1668万余50岁以上无GCA或PMR病史者,发现带状疱疹事件与巨细胞动脉炎(GCA)发病风险升高相关,复杂性和非复杂性带状疱疹均显示关联,但抗病毒治疗和疫苗接种与GCA风险的关系不一致。

要点

  • 复杂性和非复杂性带状疱疹均与GCA发病风险升高相关。
  • 抗病毒治疗和疫苗接种未一致降低GCA风险。
  • 带状疱疹在GCA患者中不常见,可能仅是潜在触发因素之一。

核心结论

  • 带状疱疹与巨细胞动脉炎发病风险升高相关,但带状疱疹在GCA患者中不常见,提示其仅为潜在触发因素之一。

研究设计与样本

  • 美国两个独立大型行政数据库(Medicare 5%和Truven Health Analytics MarketScan)的回顾性队列研究,纳入年龄>50岁、连续覆盖12个月、无GCA或风湿性多肌痛病史的受试者。

主要发现

  • 在16,686,345名受试者中共发生5,942例GCA,其中MarketScan队列3.1%、Medicare队列6.0%有 preceding 带状疱疹事件。
  • 多变量调整后,复杂性带状疱疹与GCA风险升高相关:Medicare队列HR 1.99(95%CI 1.32-3.02),MarketScan队列HR 2.16(95%CI 1.46-3.18)。
  • 非复杂性带状疱疹也与GCA风险升高相关:Medicare队列HR 1.42(95%CI 1.02-1.99),MarketScan队列HR 1.45(95%CI 1.05-2.01)。
  • 抗病毒治疗和疫苗接种与GCA风险无一致关联,但Medicare队列中抗病毒治疗与GCA风险降低边缘相关(HR 0.67,95%CI 0.46-0.99)。

临床怎么用

  • 对于50岁以上有带状疱疹病史的患者,尤其是复杂性带状疱疹,应警惕GCA发生的可能性。
  • 抗病毒治疗和疫苗接种对GCA风险的降低作用不一致,不能作为常规预防GCA的依据。

局限性

  • 本研究为回顾性队列研究,使用行政数据编码识别疾病,可能存在编码错误或漏诊。
  • 研究未明确带状疱疹与GCA的时间关系,且未纳入临床详细资料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Histopathologic studies have implicated herpes zoster (HZ) as a causative organism of giant cell arteritis (GCA). The purpose of this study was to assess the epidemiologic association of HZ events with incident GCA. METHODS: We performed a retrospective cohort study in 2 large independent US administrative data sets: Medicare 5% and Truven Health Analytics MarketScan. Eligible subjects had 12 months of continuous coverage, were >50 years old, and had no history of GCA or polymyalgia rheumatica. HZ events (complicated and uncomplicated) and GCA were identified by the presence of International Classification of Diseases, Ninth Revision, Clinical Modification codes from physician visit or hospital discharge records. Antiviral therapies and vaccinations were identified from prescription claims and drug codes. Risk of incident GCA was calculated using multivariable Cox proportional hazards regression. RESULTS: Among 16,686,345 subjects, a total of 5,942 GCA cases occurred, with 3.1% (MarketScan) and 6.0% (Medicare) having preceding HZ events. Unadjusted GCA incidence rates were highest in the groups with complicated and uncomplicated HZ. After multivariable adjustment, complicated HZ was associated with an increased risk of GCA (hazard ratio [HR] 1.99 [95% confidence interval (95% CI) 1.32-3.02] in the Medicare cohort and 2.16 [95% CI 1.46-3.18] in the MarketScan cohort), as was uncomplicated HZ (HR 1.42 [95% CI 1.02-1.99] and HR 1.45 [95% CI 1.05-2.01] in the respective cohorts). Vaccination and antiviral treatment were not consistently associated with GCA risk, although antiviral treatment was marginally associated with a decreased risk of GCA in the Medicare cohort (HR 0.67 [95% CI 0.46-0.99]). CONCLUSION: HZ is associated with an increased risk of GCA. The infrequency of HZ in GCA patients suggests that it is only one potential trigger for GCA. Antivirals and vaccination did not consistently mitigate this risk.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. England BR, Mikuls TR, Xie F, et al. Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis. Arthritis Rheumatol. 2017. PMID: 28853238. doi:10.1002/art.40236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。